Cell MedX CMXC Stock
Cell MedX Price Chart
Cell MedX CMXC Financial and Trading Overview
| Cell MedX stock price | 0.03 USD |
| Previous Close | 1.0E-6 USD |
| Open | 1.0E-6 USD |
| Bid | 0 USD x 0 |
| Ask | 0 USD x 0 |
| Day's Range | 1.0E-6 - 1.0E-6 USD |
| 52 Week Range | 1.0E-6 - 0.12 USD |
| Volume | 6.1K USD |
| Avg. Volume | 0 USD |
| Market Cap | 62 USD |
| Beta (5Y Monthly) | -3.235211 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.01 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
CMXC Valuation Measures
| Enterprise Value | 747.52K USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 0.01094826 |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | 132 |
| Enterprise Value/EBITDA | -1.377 |
Trading Information
Cell MedX Stock Price History
| Beta (5Y Monthly) | -3.235211 |
| 52-Week Change | -64.39% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.12 USD |
| 52 Week Low | 1.0E-6 USD |
| 50-Day Moving Average | 0.03 USD |
| 200-Day Moving Average | 0.04 USD |
CMXC Share Statistics
| Avg. Volume (3 month) | 0 USD |
| Avg. Daily Volume (10-Days) | 0 USD |
| Shares Outstanding | 62.92M |
| Float | 37.85M |
| Short Ratio | N/A |
| % Held by Insiders | 39.85% |
| % Held by Institutions | 0% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | May 31, 2022 |
| Most Recent Quarter (mrq) | November 30, 2022 |
| Next Fiscal Year End | May 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -9602.66% |
| Gross Margin | 45.84% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -703.70% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | 5.66K USD |
| Revenue Per Share (ttm) | 0 USD |
| Quarterly Revenue Growth (yoy) | 16.69% |
| Gross Profit (ttm) | N/A |
| EBITDA | -542824 USD |
| Net Income Avi to Common (ttm) | -579548 USD |
| Diluted EPS (ttm) | 0 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 17.81K USD |
| Total Cash Per Share (mrq) | 0 USD |
| Total Debt (mrq) | 765.27K USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 0.011 |
| Book Value Per Share (mrq) | -0.035 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -325563 USD |
| Levered Free Cash Flow (ttm) | -224196 USD |
Profile of Cell MedX
| Country | United States |
| State | NV |
| City | Carson City |
| Address | 123 West Nye Lane |
| ZIP | 89706 |
| Phone | 844 238 2692 |
| Website | https://cellmedx.com |
| Industry | Medical Devices |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Cell MedX Corp., a biotech company, discovers, develops, and commercializes therapeutic and non-therapeutic products for patients with diabetes, Parkinson's disease, high blood pressure, neuropathy, and kidney functions. It develops and manufactures eBalance Pro System for professional use by healthcare practitioners in a clinical setting; and eBalance Home System for home use for general wellness and pain management treatment, which are controlled by the eBalance Console that acts as the central controller for three pre-programmed microcurrent algorithms, including wellness, pain management, and dual. The company was formerly known as Sports Asylum, Inc. and changed its name to Cell MedX Corp. in September 2014. Cell MedX Corp. was incorporated in 2010 and is headquartered in Carson City, Nevada.
Q&A For Cell MedX Stock
What is a current CMXC stock price?
Cell MedX CMXC stock price today per share is 0.03 USD.
How to purchase Cell MedX stock?
You can buy CMXC shares on the Other OTC exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Cell MedX?
The stock symbol or ticker of Cell MedX is CMXC.
Which industry does the Cell MedX company belong to?
The Cell MedX industry is Medical Devices.
How many shares does Cell MedX have in circulation?
The max supply of Cell MedX shares is 294.74M.
What is Cell MedX Price to Earnings Ratio (PE Ratio)?
Cell MedX PE Ratio is now.
What was Cell MedX earnings per share over the trailing 12 months (TTM)?
Cell MedX EPS is -0.01 USD over the trailing 12 months.
Which sector does the Cell MedX company belong to?
The Cell MedX sector is Healthcare.